SOX9 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

159 results for “SOX9”

Trials

View all 155 →

SOX2 & PDL1 Expression on Urinary Bladder Carcinoma

60 participants · First posted Jun 23, 2022

Not yet recruiting

QL1706-SOX vs SOX Alone as Neoadjuvant Therapy for Resectable Diffuse-Type Gastric Cancer

74 participants · First posted Jan 2, 2026

Study to Evaluate the Efficiency of SOX as Seconde-line Chemotherapy in Neuroendocrine Carcinoma

45 participants · First posted Sep 12, 2017

Drugs

SOX9 gene therapy (dermatological disease)

News

Trogenix's Gene Therapy Achieves 83% Complete Tumor Elimination in Glioblastoma Model, Nature Study Shows

Ferroptosis-Inducing Drug Auranofin Shows Promise in Combination with Chemotherapy for Resistant Neuroblastoma

Piezo1: The Mechanosensitive Ion Channel at the Crossroads of Bone Health and Orthopedic Disease

Page 1 of 16